Spine BioPharma Email Format

Biotechnology ResearchNew York, United States2-10 Employees

Spine BioPharma is a biotechnology research company focused on developing non-opioid, non-surgical therapies for chronic low back pain caused by degenerative disc disease. Its work aims to relieve pain and restore function without invasive procedures or opioid medications. The company is based in New York City and operates with a small-to-mid-sized team.

Its target market includes patients worldwide seeking alternatives to surgery and opioids, along with clinicians who treat back-pain conditions. The organization positions itself in the biotechnology research space by pursuing non-opioid, non-surgical approaches to address disability from chronic back pain. In 2025, Spine BioPharma participated in industry conferences, including presenting at the Canaccord Genuity 2025 Musculoskeletal Conference and Biotech Showcase 2025.

Sign up for free to view info

Company overview Employee directory